Evaluation of sorafenib for hepatocellular carcinoma by contrast-enhanced ultrasonography: A pilot study

AIM: To determine the usefulness of arrival time parametric imaging (AtPI) using contrast-enhanced ultrasonography (CEUS) with Sonazoid in evaluating early response to sorafenib for hepatocellular carcinoma (HCC). METHODS: Fourteen advanced HCC patients who received sorafenib 400/800 mg/d for at lea...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shiozawa, Kazue, Watanabe, Manabu, Kikuchi, Yoshinori, Kudo, Takahide, Maruyama, Kenichi, Sumino, Yasukiyo
Formato: Artigo
Lenguaje:Inglês
Publicado: Baishideng Publishing Group Co., Limited 2012
Materias:
Brief Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3484345/
https://ncbi.nlm.nih.gov/pubmed/23155317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v18.i40.5753
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares